Celon Pharma S.A. (WSE: CLN)
Poland
· Delayed Price · Currency is PLN
27.50
-0.10 (-0.36%)
Sep 27, 2024, 3:34 PM CET
Celon Pharma Revenue
Celon Pharma had revenue of 65.62M PLN in the quarter ending June 30, 2024, a decrease of -3.44%. This brings the company's revenue in the last twelve months to 206.81M, down -2.00% year-over-year. In the year 2023, Celon Pharma had annual revenue of 213.92M with 10.33% growth.
Revenue (ttm)
206.81M
Revenue Growth
-2.00%
P/S Ratio
6.75
Revenue / Employee
365.39K
Employees
515
Market Cap
1.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 213.92M | 20.04M | 10.33% |
Dec 31, 2022 | 193.89M | -2.20M | -1.12% |
Dec 31, 2021 | 196.09M | 38.64M | 24.54% |
Dec 31, 2020 | 157.45M | 55.20M | 53.99% |
Dec 31, 2019 | 102.25M | -23.00M | -18.36% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.06B |
NEUCA S.A. | 12.13B |
Sopharma AD | 4.35B |
Synektik Spólka Akcyjna | 618.67M |
Ryvu Therapeutics S.A. | 82.39M |
Voxel S.A. | 476.19M |
Selvita S.A. | 329.02M |
Mercator Medical S.A. | 475.63M |